Navigasjon

  • Hopp til innhold
NTNU Hjemmeside NTNU Hjemmeside

ntnu.no

  • Studier
    • Studere på NTNU
    • Finn studieprogram
    • Søke opptak
    • Videreutdanning og deltid
    • Forkurs og oppfriskning
  • Studentliv
    • Student i Gjøvik
    • Student i Trondheim
    • Student i Ålesund
  • Forskning og innovasjon
    • Forskning
    • Innovasjon
    • Satsingsområder
    • Toppforskning
    • Ekspertlister
    • Ph.d.
  • Om NTNU
    • Fakulteter og institutter
    • Sentre
    • Bibliotek
    • Kart
    • Ledige stillinger
    • Arrangement
    • Nyheter
    • Kontakt oss
    • Om NTNU
  1. Ansatte

Språkvelger

English

Mari Nordbo Gynnild

Last ned pressefoto
Last ned pressefoto
Foto:

Mari Nordbo Gynnild

Postdoktor
Institutt for sirkulasjon og bildediagnostikk

mari.nordbo.gynnild@ntnu.no
AHL-senteret, Øya, Prinsesse Kristinas gt 3
Twitter ResearchGate AG Preventiv Young Ambassador EAPC
Om Forskning Publikasjoner Undervisning Formidling

Om

Mari Nordbø Gynnild er lege i spesialisering i indremedisin og kardiologi ved Klinikk for hjertemedisin, St. Olavs Hospital, og forsker ved K.G. Jebsen Center for Cardiac Biomarkers, Institutt for klinisk medisin, Universitetet i Oslo.

Hun er utdannet lege fra NTNU (2013) og har en doktorgrad fra NTNU (2022) i samarbeid med University Medical Center Utrecht som omhandler etterlevelse for medikamentell sekundærforebygging og hvordan man kan forutsi risiko for fremtidige hjerte- og karhendelser.

Forskningen hennes omfatter risikovurdering og forebygging av hjerte- og karsykdom, kardio-onkologi og ekkokardiografi. Hun er postdoktor i den randomiserte PRADA II-studien som undersøker om hjertemedisinen sacubitril/valsartan kan forebygge hjerteskade hos brystkreftpasienter som får cellegiftbehandling. Hun er prosjektleder for prosjektet "Risk prediction for individualized cardiovascular disease prevention" (REK 590420) og samarbeider internasjonalt om å teste og forbedre modeller som forutsier risiko for hjerte- og karsykdom.

Kompetanseord

  • Antikoagulasjonsbehandling
  • Compliance
  • Etterlevelse
  • Farmakologi
  • Hjerneslag
  • Hjerte og karsykdom
  • Hjertesvikt
  • Hypertensjon
  • Kardioonkologi
  • Kardiovaskulær medisin
  • Kardiovaskulære sykdommer

Forskning

PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial

A randomized, placebo-controlled, multicenter trial assessing if sacubitril/valsartan given concomitantly with early breast cancer treatment regimens including anthracyclines, with or without trastuzumab, may prevent cardiac dysfunction.

Risk prediction for individualized cardiovascular disease prevention

This project aims to externally validate and compare guideline-recommended cardiovascular risk prediction tools, as well as tailor models to local settings, new settings and investigate whether these models can be extended by addition of new predictors.

Publikasjoner

  • Kronologisk
  • Etter kategori
  • Alle publikasjoner i Nasjonalt vitenarkiv (NVA)

2025

  • Gynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven H J; Vinje, Victoria; Dorresteijn, Jannick A N; Visseren, Frank L J. (2025) External validation of the systematic coronary risk evaluation 2 (SCORE2) and SCORE2-older persons in cancer patients. European Journal of Preventive Cardiology (EJPC)
    Vitenskapelig artikkel
  • Gynnild, Mari Nordbø; Vinje-Jakobsen, Victoria; Holtrop, Joris; Hageman, Steven H.J.; Holte, Espen; Gulati, Geeta. (2025) Prognostic Performance of a Modified HFA-ICOS Tool for Prediction of Cardiovascular Complications in Cancer Patients. JACC: Advances
    Vitenskapelig artikkel
  • Gynnild, Mari Nordbø; Hageman, Steven; Holtrop, Joris; Holte, Espen; Dalen, Håvard; Wethal, Torgeir. (2025) Improved risk stratification with SCORE2 on top of HFA-ICOS in cancer patients without previous cardiovascular disease. European Heart Journal, Supplement
    Vitenskapelig artikkel
  • Reitsma, Tessa; Holtrop, Joris; Gynnild, Mari Nordbø; Lim, Carl Emil; Pennells, Lisa; Keene, Spencer. (2025) Lifetime prediction of incident heart failure risk in patients with established atherosclerotic cardiovascular disease: the SMART2-HF risk score. European Heart Journal, Supplement
    Vitenskapelig artikkel
  • Hageman, Steven H J; Kaptoge, Stephen; Gynnild, Mari Nordbø; Holtrop, Joris; Pennells, Lisa; McEvoy, J William. (2025) Using SCORE2 with a risk chart or online calculator: impact on model performance, treatment eligibility, and cardiovascular disease prevention. European Heart Journal - Quality of Care and Clinical Outcomes
    Vitenskapelig artikkel
  • Holtrop, Joris; Gynnild, Mari Nordbø; Dammen, Toril; Dalen, Håvard; Saltvedt, Ingvild Tina; Ellekjær, Hanne. (2025) Psychological factors beyond the SMART2 model for predicting recurrent events in atherosclerotic cardiovascular disease patients. European Journal of Preventive Cardiology (EJPC)
    Vitenskapelig artikkel
  • Omland, Torbjørn; Heck, Siri Lagethon; Holte, Espen; Lilleaasen, Albulena Mecinaj; Gynnild, Mari Nordbø; Fagerland, Morten. (2025) Sacubitril-Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial. Circulation
    Vitenskapelig artikkel
  • Sande, Ingvild Svorkdal; Helgheim, Kamilla Lind; Saltveddt, Ingvild; Røsstad, Tove Garåsen; Spigset, Olav; Ellekjær, Hanne. (2025) Follow-Up in Primary Care After Ischemic Stroke - Insights From the Nor-COAST Study. International Journal of General Medicine
    Vitenskapelig artikkel
  • Fagerli, Erlend; Ellekjær, Hanne; Spigset, Olav; SALTVEDT, INGVILD; Gynnild, Mari Nordbø. (2025) Three-year adherence to secondary prevention and vascular risk control after ischemic stroke. European Stroke Journal
    Vitenskapelig artikkel
  • Hageman, Steven HJ; Kaptoge, Steven; Gynnild, Mari Nordbø; Pennels, Lisa; Pajak, Andrzej; Pikhart, Hynek. (2025) Assessment of CV risk by SCORE2 with an online calculator estimates CV risk better compared to 2-dimensional risk charts. European Journal of Preventive Cardiology (EJPC)
    Fagartikkel
  • Holtrop, Joris; Gynnild, Mari Nordbø; Dammen, Toril; Dalen, Håvard; Hageman, Steven HJ; Visseren, Frank. (2025) Integration of psychological risk modifiers on-top the SMART2-risk score for estimation of recurrent cardiovascular events in patients with atherosclerotic cardiovascular disease. European Journal of Preventive Cardiology (EJPC)
    Fagartikkel
  • Gynnild, Mari Nordbø; Holtrop, Joris; Dalen, Håvard; Dorresteijn, Jannick; Visseren, Frank; Holte, Espen. (2025) Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors. European Journal of Preventive Cardiology (EJPC)
    Vitenskapelig artikkel

2024

  • Gynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven HJ; Vinje, Victoria; Dorresteijn, Jannick AN; Visseren, Frank. (2024) External validation of the HFA-ICOS risk stratification tool for prediction of cardiovascular complications after cancer treatment. European Heart Journal, Supplement
    Sammendrag/Abstract
  • Gynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven HJ; Vinje, Victoria; Dorresteijn, Jannick AN; Visseren, Frank. (2024) External validation of the Systematic COronary Risk Evaluation 2 (SCORE2) model in cancer patients. European Heart Journal, Supplement
    Sammendrag/Abstract
  • Gynnild, Mari Nordbø. (2024) Kardiovaskulær risikostratifisering. Hjerteforum
    Leserinnlegg
  • Holtrop, Joris; Gynnild, Mari Nordbø; Munkhaugen, John; Dalen, Håvard; Lim, Carl-Emil; Ueda, Peter. (2024) Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model. European Heart Journal, Supplement
    Sammendrag/Abstract

2023

  • Aakerøy, Rachel; Gynnild, Mari Nordbø; Løfblad, Lena; Dyrkorn, Roar; Ellekjær, Hanne; Lydersen, Stian. (2023) Direct oral anticoagulant concentrations and adherence in stroke patients. Basic & Clinical Pharmacology & Toxicology
    Vitenskapelig artikkel

2022

  • Gynnild, Mari Nordbø; Ellekjær, Hanne; Spigset, Olav; Røsstad, Tove; Næss, Halvor. (2022) RESIDUAL CARDIOVASCULAR RISK AFTER ISCHEMIC STROKE Risk factors, medication adherence and risk-benefit considerations. Norges teknisk-naturvitenskapelige universitet Norges teknisk-naturvitenskapelige universitet
    Doktorgradsavhandling
  • Hageman, Steven HJ; McKay, Ailsa; Ueda, Peter; Gunn, Laura; Jernberg, Tomas; Hagström, Emil. (2022) Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: The updated SMART2 algorithm. European Heart Journal
    Vitenskapelig artikkel
  • Gynnild, Mari Nordbø; Hageman, Steven H. J.; Spigset, Olav; Lydersen, Stian; Saltvedt, Ingvild; Dorresteijn, Jannick AN. (2022) Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment. Open heart
    Vitenskapelig artikkel

2021

  • Gynnild, Mari Nordbø; Hageman, Steven HJ; Dorresteijn, Jannick AN; Spigset, Olav; Lydersen, Stian; Wethal, Torgeir. (2021) Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention. Clinical Epidemiology
    Vitenskapelig artikkel
  • Aam, Stina; Gynnild, Mari Nordbø; Munthe-Kaas, Ragnhild; Saltvedt, Ingvild; Lydersen, Stian; Knapskog, Anne Brita. (2021) The Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment: The Nor-COAST Study. Frontiers in Neurology
    Vitenskapelig artikkel

2020

  • Gynnild, Mari Nordbø; Aakerøy, Rachel; Spigset, Olav; Askim, Torunn; Beyer, Mona Kristiansen; Ihle-Hansen, Hege. (2020) Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke. Journal of Internal Medicine
    Vitenskapelig artikkel

2014

  • Anshushaug, Malin; Gynnild, Mari Aas; Kaasa, Stein; Kvikstad, Anne; Grønberg, Bjørn H.. (2014) Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Acta Oncologica
    Vitenskapelig artikkel

Tidsskriftspublikasjoner

  • Gynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven H J; Vinje, Victoria; Dorresteijn, Jannick A N; Visseren, Frank L J. (2025) External validation of the systematic coronary risk evaluation 2 (SCORE2) and SCORE2-older persons in cancer patients. European Journal of Preventive Cardiology (EJPC)
    Vitenskapelig artikkel
  • Gynnild, Mari Nordbø; Vinje-Jakobsen, Victoria; Holtrop, Joris; Hageman, Steven H.J.; Holte, Espen; Gulati, Geeta. (2025) Prognostic Performance of a Modified HFA-ICOS Tool for Prediction of Cardiovascular Complications in Cancer Patients. JACC: Advances
    Vitenskapelig artikkel
  • Gynnild, Mari Nordbø; Hageman, Steven; Holtrop, Joris; Holte, Espen; Dalen, Håvard; Wethal, Torgeir. (2025) Improved risk stratification with SCORE2 on top of HFA-ICOS in cancer patients without previous cardiovascular disease. European Heart Journal, Supplement
    Vitenskapelig artikkel
  • Reitsma, Tessa; Holtrop, Joris; Gynnild, Mari Nordbø; Lim, Carl Emil; Pennells, Lisa; Keene, Spencer. (2025) Lifetime prediction of incident heart failure risk in patients with established atherosclerotic cardiovascular disease: the SMART2-HF risk score. European Heart Journal, Supplement
    Vitenskapelig artikkel
  • Hageman, Steven H J; Kaptoge, Stephen; Gynnild, Mari Nordbø; Holtrop, Joris; Pennells, Lisa; McEvoy, J William. (2025) Using SCORE2 with a risk chart or online calculator: impact on model performance, treatment eligibility, and cardiovascular disease prevention. European Heart Journal - Quality of Care and Clinical Outcomes
    Vitenskapelig artikkel
  • Holtrop, Joris; Gynnild, Mari Nordbø; Dammen, Toril; Dalen, Håvard; Saltvedt, Ingvild Tina; Ellekjær, Hanne. (2025) Psychological factors beyond the SMART2 model for predicting recurrent events in atherosclerotic cardiovascular disease patients. European Journal of Preventive Cardiology (EJPC)
    Vitenskapelig artikkel
  • Omland, Torbjørn; Heck, Siri Lagethon; Holte, Espen; Lilleaasen, Albulena Mecinaj; Gynnild, Mari Nordbø; Fagerland, Morten. (2025) Sacubitril-Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial. Circulation
    Vitenskapelig artikkel
  • Sande, Ingvild Svorkdal; Helgheim, Kamilla Lind; Saltveddt, Ingvild; Røsstad, Tove Garåsen; Spigset, Olav; Ellekjær, Hanne. (2025) Follow-Up in Primary Care After Ischemic Stroke - Insights From the Nor-COAST Study. International Journal of General Medicine
    Vitenskapelig artikkel
  • Fagerli, Erlend; Ellekjær, Hanne; Spigset, Olav; SALTVEDT, INGVILD; Gynnild, Mari Nordbø. (2025) Three-year adherence to secondary prevention and vascular risk control after ischemic stroke. European Stroke Journal
    Vitenskapelig artikkel
  • Hageman, Steven HJ; Kaptoge, Steven; Gynnild, Mari Nordbø; Pennels, Lisa; Pajak, Andrzej; Pikhart, Hynek. (2025) Assessment of CV risk by SCORE2 with an online calculator estimates CV risk better compared to 2-dimensional risk charts. European Journal of Preventive Cardiology (EJPC)
    Fagartikkel
  • Holtrop, Joris; Gynnild, Mari Nordbø; Dammen, Toril; Dalen, Håvard; Hageman, Steven HJ; Visseren, Frank. (2025) Integration of psychological risk modifiers on-top the SMART2-risk score for estimation of recurrent cardiovascular events in patients with atherosclerotic cardiovascular disease. European Journal of Preventive Cardiology (EJPC)
    Fagartikkel
  • Gynnild, Mari Nordbø; Holtrop, Joris; Dalen, Håvard; Dorresteijn, Jannick; Visseren, Frank; Holte, Espen. (2025) Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors. European Journal of Preventive Cardiology (EJPC)
    Vitenskapelig artikkel
  • Gynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven HJ; Vinje, Victoria; Dorresteijn, Jannick AN; Visseren, Frank. (2024) External validation of the HFA-ICOS risk stratification tool for prediction of cardiovascular complications after cancer treatment. European Heart Journal, Supplement
    Sammendrag/Abstract
  • Gynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven HJ; Vinje, Victoria; Dorresteijn, Jannick AN; Visseren, Frank. (2024) External validation of the Systematic COronary Risk Evaluation 2 (SCORE2) model in cancer patients. European Heart Journal, Supplement
    Sammendrag/Abstract
  • Gynnild, Mari Nordbø. (2024) Kardiovaskulær risikostratifisering. Hjerteforum
    Leserinnlegg
  • Holtrop, Joris; Gynnild, Mari Nordbø; Munkhaugen, John; Dalen, Håvard; Lim, Carl-Emil; Ueda, Peter. (2024) Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model. European Heart Journal, Supplement
    Sammendrag/Abstract
  • Aakerøy, Rachel; Gynnild, Mari Nordbø; Løfblad, Lena; Dyrkorn, Roar; Ellekjær, Hanne; Lydersen, Stian. (2023) Direct oral anticoagulant concentrations and adherence in stroke patients. Basic & Clinical Pharmacology & Toxicology
    Vitenskapelig artikkel
  • Hageman, Steven HJ; McKay, Ailsa; Ueda, Peter; Gunn, Laura; Jernberg, Tomas; Hagström, Emil. (2022) Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: The updated SMART2 algorithm. European Heart Journal
    Vitenskapelig artikkel
  • Gynnild, Mari Nordbø; Hageman, Steven H. J.; Spigset, Olav; Lydersen, Stian; Saltvedt, Ingvild; Dorresteijn, Jannick AN. (2022) Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment. Open heart
    Vitenskapelig artikkel
  • Gynnild, Mari Nordbø; Hageman, Steven HJ; Dorresteijn, Jannick AN; Spigset, Olav; Lydersen, Stian; Wethal, Torgeir. (2021) Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention. Clinical Epidemiology
    Vitenskapelig artikkel
  • Aam, Stina; Gynnild, Mari Nordbø; Munthe-Kaas, Ragnhild; Saltvedt, Ingvild; Lydersen, Stian; Knapskog, Anne Brita. (2021) The Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment: The Nor-COAST Study. Frontiers in Neurology
    Vitenskapelig artikkel
  • Gynnild, Mari Nordbø; Aakerøy, Rachel; Spigset, Olav; Askim, Torunn; Beyer, Mona Kristiansen; Ihle-Hansen, Hege. (2020) Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke. Journal of Internal Medicine
    Vitenskapelig artikkel
  • Anshushaug, Malin; Gynnild, Mari Aas; Kaasa, Stein; Kvikstad, Anne; Grønberg, Bjørn H.. (2014) Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Acta Oncologica
    Vitenskapelig artikkel

Rapport

  • Gynnild, Mari Nordbø; Ellekjær, Hanne; Spigset, Olav; Røsstad, Tove; Næss, Halvor. (2022) RESIDUAL CARDIOVASCULAR RISK AFTER ISCHEMIC STROKE Risk factors, medication adherence and risk-benefit considerations. Norges teknisk-naturvitenskapelige universitet Norges teknisk-naturvitenskapelige universitet
    Doktorgradsavhandling

Undervisning

Master i farmasi (MFARMASI)

Veiledning

Hovedoppgaver ved Profesjonsstudiet i medisin, NTNU. 

Formidling

2025

  • Vitenskapelig foredrag
    Reitsma, Tessa; Holtrop, Joris; Gynnild, Mari Nordbø; Lim, Carl E; Pennels, Lisa; Keene, Spencer. (2025) Lifetime prediction of incident heart failure risk in patients with established atherosclerotic cardiovascular disease: the SMART2-HF risk score. ESC Congress Madrid 2025 , Madrid 2025-08-28 - 2025-08-31
  • Vitenskapelig foredrag
    Gynnild, Mari Nordbø; Hageman, Steven; Holtrop, Joris; Holte, Espen; Dalen, Håvard; Wethal, Torgeir. (2025) Improved risk stratification with SCORE2 on top of HFA-ICOS in cancer patients without previous cardiovascular disease. ESC Congress Madrid 2025 , Madrid 2025-08-28 - 2025-08-31
  • Vitenskapelig foredrag
    Hageman, Steven H. J.; Kaptoge, Stephen; Gynnild, Mari Nordbø; Holtrop, Joris; Pennels, Lisa; McEvoy, John William. (2025) Using SCORE2 with a risk chart or online calculator: Impact on model performance, treatment eligibility and cardiovascular disease prevention. ESC Preventive Cardiology 2025 , Milan 2025-04-03 - 2025-04-05
  • Vitenskapelig foredrag
    Gynnild, Mari Nordbø; Holtrop, Joris; Dorresteijn, Jannick A. N.; Visseren, F.L.J.; Dalen, Håvard; Holte, Espen. (2025) Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors. ESC Preventive Cardiology 2025 , Milan 2025-04-03 - 2025-04-05
  • Vitenskapelig foredrag
    Holtrop, Joris; Gynnild, Mari Nordbø; Dalen, Håvard; Dammen, Toril; McEvoy, John William; Hageman, Steven H. J.. (2025) Integration of guideline-recommended psychosocial risk modifiers on-top the SMART2-risk score for estimation of recurrent cardiovascular events in patients with established cardiovascular disease. ESC Preventive Cardiology 2025 , Milan 2025-04-03 - 2025-04-05

2024

  • Vitenskapelig foredrag
    Holtrop, Joris; Gynnild, Mari Nordbø; Ueda, Peter; Tuñón, José; Bhat, Deepak; Jernberg, Thomas. (2024) Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model. ESC Congress London , London 2024-08-29 - 2024-09-02
  • Vitenskapelig foredrag
    Gynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven; Vinje, Victoria; Dorresteijn, Jannick; Visseren, Frank. (2024) External validation of the Systematic COronary Risk Evaluation 2 (SCORE2) model in cancer patients. ESC Congress London , London 2024-08-29 - 2024-09-02
  • Vitenskapelig foredrag
    Gynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven; Vinje, Victoria; Dorresteijn, Jannick A.N.; Visseren, Frank. (2024) External validation of the HFA-ICOS risk stratification tool for prediction of cardiovascular complications after cancer treatment. ESC Congress London , London 2024-08-29 - 2024-09-02

2022

  • Faglig foredrag
    Gynnild, Mari Nordbø. (2022) Etterlevelse av forbyggende behandling, er vi sammen gode nok?. Geriatrikongressen 2022-04-04 - 2022-04-05
  • Intervju
    Gynnild, Mari Nordbø. (2022) Under halvparten nådde de anbefalte målene for blodtrykk og kolesterol. Dagens Medisin Dagens Medisin [null] 2022-05-18

2021

  • Faglig foredrag
    Gynnild, Mari Nordbø. (2021) Optimalisert etterlevelse for sekundærprofylaktiske legemidler. Bergenskonferansen, Norsk hjerneslagforening , Bergen 2021-10-20 - 2021-10-21

2020

  • Poster
    Gynnild, Mari Nordbø; Aakerøy, Rachel; Spigset, Olav; Ellekjær, Hanne. (2020) Adherence to secondary preventive anticoagulation and risk for subsequent stroke and death. European Stroke Organisation and World Stroke Organization (ESO-WSO 2020) Virtual Conference , Wien 2020-11-07 - 2020-11-09

2018

  • Poster
    Gynnild, Mari Nordbø; Ellekjær, Hanne. (2018) Adherence to secondary prevention after stroke. European Stroke Organisation Conference (ESOC) , Göteborg, Sweden 2018-05-16 - 2018-05-18

NTNU – Norges teknisk-naturvitenskapelige universitet

  • For ansatte
  • |
  • For studenter
  • |
  • Innsida
  • |
  • Blackboard

Studere

  • Om studier
  • Studieprogram
  • Emner
  • Videreutdanning
  • Karriere

Aktuelt

  • Nyheter
  • Arrangement
  • Jobbe ved NTNU

Om NTNU

  • Om NTNU
  • Bibliotek
  • Strategi
  • Forskning
  • Satsingsområder
  • Innovasjon
  • Organisasjonskart
  • Utdanningskvalitet

Kontakt

  • Kontakt oss
  • Finn ansatte
  • Spør en ekspert
  • Pressekontakter
  • Kart

NTNU i tre byer

  • NTNU i Gjøvik
  • NTNU i Trondheim
  • NTNU i Ålesund

Om nettstedet

  • Bruk av informasjonskapsler
  • Tilgjengelighetserklæring
  • Personvern
  • Ansvarlig redaktør
Facebook Instagram Linkedin Snapchat Tiktok Youtube
Logg inn
NTNU logo